Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
1.590
+0.010 (0.63%)
At close: Jul 26, 2024, 4:00 PM
1.530
-0.060 (-3.77%)
After-hours: Jul 26, 2024, 5:57 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $266.18 million as of July 26, 2024. Its market cap has decreased by -18.20% in one year.
Market Cap
266.18M
Enterprise Value
175.21M
1-Year Change
-18.20%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $266.18M, a decrease of -88.37%. That is a compound annual growth rate of -50.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 264.50M | 12.99% |
| Dec 29, 2023 | 234.10M | -46.94% |
| Dec 30, 2022 | 441.20M | -63.93% |
| Dec 31, 2021 | 1.22B | -46.56% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AirSculpt Technologies | 270.00M |
| Auna SA | 270.00M |
| Immutep | 269.05M |
| Artiva Biotherapeutics | 268.17M |
| Profound Medical | 266.03M |
| AVITA Medical | 263.16M |
| Zevra Therapeutics | 260.75M |
| Cibus | 259.08M |